Rocket Pharmaceuticals, Inc. (RCKT)
3.11
+0.14
(+4.71%)
USD |
NASDAQ |
May 21, 16:00
3.10
-0.01
(-0.32%)
After-Hours: 19:59
Rocket Pharmaceuticals Research and Development Expense (TTM) : 131.80M for March 31, 2026
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| AnaptysBio, Inc. | 128.24M |
| Arcus Biosciences, Inc. | 523.00M |
| Replimune Group, Inc. | 222.70M |
| ACADIA Pharmaceuticals, Inc. | 327.40M |
| Alnylam Pharmaceuticals, Inc. | 1.420B |